Treatment to Regress to Normoglycemia in Women with a Recent History of GDM

Summary

The purpose of the study is to determine the efficacy of semaglutide 1mg (Ozempic®) to aid recently postpartum women with dysglycemia and a history of GDM to regress to normoglycemia; thereby filling a gap in efficacious pharmacologic intervention options for clinicians to support postpartum diabetes recovery and reduce future risk of T2DM in young women.

Timeline

Start

2022-01-13

Primary completion

2026-01-01

Completion

2026-03-01

Drugs

Indications